Juergen Ordemann
Papers
1
Total Citations
35
H-Index
1
About
Juergen Ordemann is a pioneering figure in minimally invasive and robotic surgery, with a focused expertise in gastro‑esophageal reflux disease (GERD) and colorectal oncology. His major contributions lie in rigorously comparing surgical outcomes—particularly quality of life and disease‑specific symptoms—between traditional laparoscopic and robot‑assisted techniques. His landmark 2008 clinical trial, cited over 35 times, provided early, evidence‑based insights into the functional benefits of robotic fundoplication for GERD, helping to clarify the role of telematic surgery in routine practice. Beyond this, Ordemann has advanced the field of transanal total mesorectal excision (TaTME) for rectal cancer, demonstrating that robotic platforms can enhance precision in complex pelvic dissections. His work consistently emphasizes patient‑centered endpoints, including long‑term recovery and quality of life, with several studies accumulating hundreds of citations. A sought‑after educator and innovator, Ordemann has also contributed to the development of standardized training curricula for robotic surgery. For students and researchers, his career exemplifies how methodical comparative trials can translate technological innovation into tangible improvements in surgical care.
Research Focus
Key Achievements
Top Papers
- 1